tradingkey.logo
tradingkey.logo
Search

Inotiv Inc

NOTV
Add to Watchlist
0.080USD
0.0000.00%
Close 06/30, 16:00ETQuotes delayed by 15 min
2.79MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

-72.06%

6 Months

-85.38%

Year to Date

-85.79%

1 Year

-95.61%

Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
49.52%Turnover Ratio
0.080Prev. Close
0.000Low
0.00Turnover
LossP/E Static
0.04P/B
0.00%Div Yield TTM
-11.85%ROA
3.32052wk High
0.07Volume Ratio
-68.63MNet Profit
34.89MShares
-2.4863EPS TTM
3.79Beta
-74.09%ROE
0.21652wk Low
19.16%Amplitude
9.05%Gross Margin
2.79MMarket Cap
0.79Reward/Risk
9.64%Risk Rate

TradingKey Stock Score of Inotiv Inc

Currency: USD Updated: 2026-06-10

Key Insights

Inotiv Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 210 out of 390 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 3.25.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inotiv Inc's Score

Industry at a Glance

Industry Ranking
210 / 390
Overall Ranking
426 / 4581
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative-

Inotiv Inc Highlights

StrengthsRisks
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Overvalued
The company’s latest PE is -0.03, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.11M shares, decreasing 37.19% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 87.15K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 18.05.

Analyst Rating

Based on 0 analysts
--
Current Rating
3.250
Target Price
+1150.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inotiv Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Inotiv Inc Info

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Ticker SymbolNOTV
CompanyInotiv Inc
CEOLeasure (Robert W)
Websitehttps://www.inotiv.com/

FAQs

What is the current price of Inotiv Inc (NOTV)?

The current price of Inotiv Inc (NOTV) is 0.08.

What is the symbol of Inotiv Inc?

The ticker symbol of Inotiv Inc is NOTV.

What is the 52-week high of Inotiv Inc?

The 52-week high of Inotiv Inc is 3.32.

What is the 52-week low of Inotiv Inc?

The 52-week low of Inotiv Inc is 0.22.

What is the market capitalization of Inotiv Inc?

The market capitalization of Inotiv Inc is 2.79M.

What is the Earnings Per Share (EPS TTM) of Inotiv Inc (NOTV)?

The Earnings Per Share (EPS TTM) of Inotiv Inc (NOTV) is -2.11.
KeyAI